Catalyst Wire Dossier Catalyst Wire Dossier

CAREONE NAPROXEN SODIUM PM

naproxen sodium, diphenhydramine hydrochloride · American Sales Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CAREONE NAPROXEN SODIUM PM, covering 2019-05-10 to 2023-10-04. Get the full timeline:

Most recent: FDA Approved: CAREONE NAPROXEN SODIUM PM — Supplemental Application (American Sales Company)

See pricing